Sign inJoin waitlistJoin the waitlist

Christiane Querfeld

Dermatologist/Dermatopathologist · City of Hope National Medical Center

Credentials: · · · · · · ·

History

City of Hope National Medical Center
Present

Dermatopathology
1998–1999
Dermatology
1995–1998
Preliminary or Transitional Year
1994–1995
Doctor of Medicine
1990–1994

Research

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and…
Journal of Clinical Oncology · 2015 · 342 citations
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers
Review · Journal of the American Academy of Dermatology · 2014 · Last of 5 authors · Corresponding · 295 citations
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions
Review · Journal of the American Academy of Dermatology · 2014 · Last of 5 authors · Corresponding · 228 citations

Steven Rosen
61 papers
Jasmine Zain
37 papers
Joan Guitart
35 papers
Timothy Kuzel
22 papers
SH
Steven Horwitz
21 papers
Larisa Geskin
18 papers
YK
Youn-Hee Kim
18 papers
MP
Melissa Pulitzer
17 papers
PM
Patricia Myskowski
16 papers
AM
Alison Moskowitz
14 papers
OA
Oleg Akilov
11 papers
MD
Madeleine Duvic
10 papers

Grants

Cutaneous T Cell Lymphoma: A Paradigm for Dissecting Susceptibility and Resistance to Checkpoint Inhibition Therapy
National Cancer Institute · R01
Contact PI · $2.8M · Beckman Research Institute/City of Hope
2019–2025
Genomic Analysis of Cutaneous CD30+ Lymphoproliferative Disorders
National Cancer Institute · R21
PI · $482.8K · Beckman Research Institute/City of Hope
2022–2025

Clinical trials

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
Principal investigator · Recruiting
City of Hope Medical Center
2024–2026
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Principal investigator · Recruiting · Phase 1
SciTech Development, Inc.
2023–2027
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
Principal investigator · Recruiting
City of Hope Medical Center
2023–2034
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
Principal investigator · Recruiting · Phase 2
City of Hope Medical Center
2022–2028